Literature DB >> 28795510

CNGB3 mutation spectrum including copy number variations in 552 achromatopsia patients.

Anja K Mayer1, Caroline Van Cauwenbergh2,3, Christine Rother1, Britta Baumann1, Peggy Reuter1, Elfride De Baere3, Bernd Wissinger1, Susanne Kohl1.   

Abstract

Achromatopsia is a rare autosomal recessive cone disorder characterized by color vision defects, photophobia, nystagmus, and severely reduced visual acuity. The disease is caused by mutations in genes encoding crucial components of the cone phototransduction cascade (CNGA3, CNGB3, GNAT2, PDE6C, and PDE6H) or in ATF6, involved in the unfolded protein response. CNGB3 encoding the beta subunit of the cyclic nucleotide-gated ion channel in cone photoreceptors is the major achromatopsia gene. Here, we present a comprehensive spectrum of CNGB3 mutations and their prevalence in a cohort of 1074 independent families clinically diagnosed with achromatopsia. Of these, 485 (45.2%) carried mutations in CNGB3. We identified a total of 98 different potentially disease-causing CNGB3 variants, 58 of which are novel. About 10% of patients with CNGB3 mutations only harbored a single heterozygous variant. Therefore, we performed quantitative real-time PCR in 43 of such single heterozygotes in search of the missing allele, followed by microarray-based comparative genomic hybridization and breakpoint mapping. We discovered nine different heterozygous copy number variations encompassing one to 10 consecutive exons in 16 unrelated patients. Moreover, one additional patient with a homozygous CNGB3 deletion encompassing exons 4-18 was identified, highlighting the importance of CNV analysis for this gene.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CNGB3; achromatopsia; copy number variations; mutation spectrum and prevalence

Mesh:

Substances:

Year:  2017        PMID: 28795510     DOI: 10.1002/humu.23311

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  23 in total

1.  Structure of the human cone photoreceptor cyclic nucleotide-gated channel.

Authors:  Xiangdong Zheng; Zhengshan Hu; Huan Li; Jian Yang
Journal:  Nat Struct Mol Biol       Date:  2021-12-30       Impact factor: 18.361

2.  A combined RNA-seq and whole genome sequencing approach for identification of non-coding pathogenic variants in single families.

Authors:  Revital Bronstein; Elizabeth E Capowski; Sudeep Mehrotra; Alex D Jansen; Daniel Navarro-Gomez; Mathew Maher; Emily Place; Riccardo Sangermano; Kinga M Bujakowska; David M Gamm; Eric A Pierce
Journal:  Hum Mol Genet       Date:  2020-04-15       Impact factor: 6.150

3.  Accessory heterozygous mutations in cone photoreceptor CNGA3 exacerbate CNG channel-associated retinopathy.

Authors:  Markus Burkard; Susanne Kohl; Timm Krätzig; Naoyuki Tanimoto; Christina Brennenstuhl; Anne E Bausch; Katrin Junger; Peggy Reuter; Vithiyanjali Sothilingam; Susanne C Beck; Gesine Huber; Xi-Qin Ding; Anja K Mayer; Britta Baumann; Nicole Weisschuh; Ditta Zobor; Gesa-Astrid Hahn; Ulrich Kellner; Sascha Venturelli; Elvir Becirovic; Peter Charbel Issa; Robert K Koenekoop; Günther Rudolph; John Heckenlively; Paul Sieving; Richard G Weleber; Christian Hamel; Xiangang Zong; Martin Biel; Robert Lukowski; Matthias W Seeliger; Stylianos Michalakis; Bernd Wissinger; Peter Ruth
Journal:  J Clin Invest       Date:  2018-11-12       Impact factor: 19.456

Review 4.  Gene Therapy for Color Blindness.

Authors:  Mark M Hassall; Alun R Barnard; Robert E MacLaren
Journal:  Yale J Biol Med       Date:  2017-12-19

5.  Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.(Cys759Phe) variant among Spanish families.

Authors:  Raquel Pérez-Carro; Fiona Blanco-Kelly; Lilián Galbis-Martínez; Gema García-García; Elena Aller; Blanca García-Sandoval; Pablo Mínguez; Marta Corton; Ignacio Mahíllo-Fernández; Inmaculada Martín-Mérida; Almudena Avila-Fernández; José M Millán; Carmen Ayuso
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

6.  Characterization of Retinal Structure in ATF6-Associated Achromatopsia.

Authors:  Rebecca R Mastey; Michalis Georgiou; Christopher S Langlo; Angelos Kalitzeos; Emily J Patterson; Thomas Kane; Navjit Singh; Ajoy Vincent; Anthony T Moore; Stephen H Tsang; Jonathan H Lin; Marielle P Young; M Elizabeth Hartnett; Elise Héon; Susanne Kohl; Michel Michaelides; Joseph Carroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-06-03       Impact factor: 4.799

7.  Molecular and clinical characterization of Thai patients with achromatopsia: identification of three novel disease-associated variants in the CNGA3 and CNGB3 genes.

Authors:  Worapoj Jinda; Aekkachai Tuekprakhon; Wanna Thongnoppakhun; Chanin Limwongse; Adisak Trinavarat; La-Ongsri Atchaneeyasakul
Journal:  Int Ophthalmol       Date:  2020-08-31       Impact factor: 2.031

8.  Deep-intronic variants in CNGB3 cause achromatopsia by pseudoexon activation.

Authors:  Nicole Weisschuh; Marc Sturm; Britta Baumann; Isabelle Audo; Carmen Ayuso; Beatrice Bocquet; Kari Branham; Brian P Brooks; Jaume Catalá-Mora; Roberto Giorda; John R Heckenlively; Robert B Hufnagel; Samuel G Jacobson; Ulrich Kellner; Sofia Kitsiou-Tzeli; Alexandre Matet; Loreto Martorell Sampol; Isabelle Meunier; Günther Rudolph; Dror Sharon; Katarina Stingl; Berthold Streubel; Balázs Varsányi; Bernd Wissinger; Susanne Kohl
Journal:  Hum Mutat       Date:  2019-09-30       Impact factor: 4.700

9.  Novel variants identified with next-generation sequencing in Polish patients with cone-rod dystrophy.

Authors:  Anna Wawrocka; Anna Skorczyk-Werner; Katarzyna Wicher; Zuzanna Niedziela; Rafal Ploski; Malgorzata Rydzanicz; Maciej Sykulski; Jaroslaw Kociecki; Nicole Weisschuh; Susanne Kohl; Saskia Biskup; Bernd Wissinger; Maciej R Krawczynski
Journal:  Mol Vis       Date:  2018-04-26       Impact factor: 2.367

10.  Multimodal imaging including semiquantitative short-wavelength and near-infrared autofluorescence in achromatopsia.

Authors:  Alexandre Matet; Susanne Kohl; Britta Baumann; Aline Antonio; Saddek Mohand-Said; José-Alain Sahel; Isabelle Audo
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.